Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
HY001N in Neuromyelitis Optica: NCT07265206 Clinical Landscape Report 2026
16 September 2026
NCT07265206 clinical landscape for Neuromyelitis Optica: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Hydroxychloroquine Sulfate in Metabolic Dysfunction Associated Steatohepatitis: NCT07265297 Clinical Landscape Report 2026
16 September 2026
NCT07265297 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Betaine in Metabolic Dysfunction Associated Steatohepatitis: NCT07276204 Clinical Landscape Report 2026
16 September 2026
NCT07276204 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Ascuprubart in Myasthenia Gravis, Ocular: NCT07250750 Clinical Landscape Report 2026
16 September 2026
NCT07250750 clinical landscape for Myasthenia Gravis, Ocular: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fitusiran in Hemophilia: NCT07285460 Clinical Landscape Report 2026
16 September 2026
NCT07285460 clinical landscape for Hemophilia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
RAG-18 in Muscular Dystrophy, Duchenne: NCT07282652 Clinical Landscape Report 2026
16 September 2026
NCT07282652 clinical landscape for Muscular Dystrophy, Duchenne: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Inaticabtagene Autoleucel in Neuromyelitis Optica: NCT07275736 Clinical Landscape Report 2026
16 September 2026
NCT07275736 clinical landscape for Neuromyelitis Optica: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Deupirfenidone in Idiopathic Pulmonary Fibrosis: NCT07284602 Clinical Landscape Report 2026
16 September 2026
NCT07284602 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PIPE-791 in Idiopathic Pulmonary Fibrosis: NCT07284459 Clinical Landscape Report 2026
16 September 2026
NCT07284459 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Empasiprubart in Myasthenia Gravis: NCT07284420 Clinical Landscape Report 2026
16 September 2026
NCT07284420 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
INS-1202 in Amyotrophic Lateral Sclerosis: NCT07290062 Clinical Landscape Report 2026
16 September 2026
NCT07290062 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ECC-0509 in Metabolic Dysfunction Associated Steatohepatitis: NCT07288138 Clinical Landscape Report 2026
16 September 2026
NCT07288138 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…